Sanofi Sustainability Profile
Sanofi, a global healthcare leader headquartered in France, is renowned for its commitment to improving health and well-being. Founded in 2004 through the merger of Sanofi-Synthélabo and Aventis, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Operating within the pharmaceutical and biotechnology industry, Sanofi focuses on several main business areas, including prescription medicines, vaccines, and consumer healthcare products. Its core offerings, such as innovative treatments for diabetes, rare diseases, and vaccines, are distinguished by their scientific rigor and patient-centric approach. With a robust market position, Sanofi has achieved notable milestones, including advancements in immunology and oncology, solidifying its reputation as a trusted name in global health solutions.
DitchCarbon Score
How does Sanofi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanofi's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sanofi's reported carbon emissions
In 2024, Sanofi reported total greenhouse gas emissions of approximately 4,196,976,000 kg CO2e, with Scope 1 emissions at about 298,485,000 kg CO2e, Scope 2 emissions at approximately 374,349,000 kg CO2e (market-based), and Scope 3 emissions reaching about 3,822,627,000 kg CO2e. The company has set ambitious targets to reduce its carbon footprint, aiming for a 55% reduction in absolute Scope 1 and 2 emissions by 2030, compared to a 2019 baseline. Additionally, Sanofi is committed to achieving net-zero emissions across all scopes by 2045. In 2023, Sanofi's global emissions were approximately 4,448,234,000 kg CO2e, with Scope 1 emissions at about 332,470,000 kg CO2e and Scope 2 emissions at approximately 423,222,000 kg CO2e (market-based). The company also disclosed significant Scope 3 emissions of about 4,025,012,000 kg CO2e. Sanofi's climate commitments include increasing its annual sourcing of renewable electricity from 11% in 2019 to 80% by 2025 and 100% by 2030. The company has also pledged to reduce its Scope 3 emissions by 30% by 2030. These targets have been validated by the Science Based Targets initiative (SBTi), reinforcing Sanofi's commitment to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 545,114,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 677,549,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Sanofi's Industry?
How Carbon Intensive is Sanofi's Location?
Sanofi's Scope 3 Categories Breakdown
Sanofi's Scope 3 emissions, which decreased by 5% last year and increased by approximately 40% since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 69% of Scope 3 emissions.
Top Scope 3 Categories
Sanofi's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sanofi has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
GlaxoSmithKline Pakistan Limited
Frequently Asked Questions
Common questions about Sanofi's sustainability data and climate commitments